AEGFX
Price
$58.70
Change
-$0.79 (-1.33%)
Updated
Jun 13 closing price
Net Assets
132.56B
HNCRX
Price
$19.60
Change
-$0.34 (-1.71%)
Updated
Jun 13 closing price
Net Assets
323.39M
Interact to see
Advertisement

AEGFX vs HNCRX

Header iconAEGFX vs HNCRX Comparison
Open Charts AEGFX vs HNCRXBanner chart's image
American Funds EUPAC F1
Price$58.70
Change-$0.79 (-1.33%)
VolumeN/A
Net Assets132.56B
Hartford International Growth R3
Price$19.60
Change-$0.34 (-1.71%)
VolumeN/A
Net Assets323.39M
AEGFX vs HNCRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEGFX vs. HNCRX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEGFX is a Buy and HNCRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEGFX has more cash in the bank: 133B vs. HNCRX (323M). AEGFX pays higher dividends than HNCRX: AEGFX (1.00) vs HNCRX (0.00). AEGFX was incepted earlier than HNCRX: AEGFX (24 years) vs HNCRX (18 years). HNCRX (1.61) is less costly to investors than AEGFX (0.86). HNCRX (31.00) and AEGFX (30.00) have comparable annual turnover. HNCRX has a lower initial minimum investment than AEGFX: HNCRX (0) vs AEGFX (250). HNCRX annual gain was more profitable for investors over the last year : 12.64 vs. AEGFX (3.51). HNCRX return over 5 years is better than : 35.59 vs. AEGFX (18.85).
AEGFXHNCRXAEGFX / HNCRX
Total Expense Ratio0.861.5755%
Annual Report Gross Expense Ratio0.861.6153%
Fund Existence24 years18 years-
Gain YTD9.80213.95370%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets133B323M41,176%
Annual Yield % from dividends1.000.00-
Returns for 1 year3.5112.6428%
Returns for 3 years25.7750.0352%
Returns for 5 years18.8535.5953%
Returns for 10 years21.7049.3644%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNLX3.060.41
+15.47%
Genelux Corp
BMRN56.22-1.06
-1.85%
BioMarin Pharmaceutical
CWK10.41-0.39
-3.61%
Cushman & Wakefield plc
DNTH18.31-0.98
-5.08%
Dianthus Therapeutics
ADIL0.35-0.10
-21.94%
Adial Pharmaceuticals